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Abstract: Type 2 Diabetes Mellitus (T2DM) is the more common type of diabetes 
results from the ineffective use of insulin. Improvement of the metabolic system in 
T2DM patients can be done through the regulation of gut microbiota balance. Gut 
microbial improvement can be modulated directly by probiotic food consumption. 
Soygurt is probiotic food with a low glycemic index (GI) and glycemic load (GL) value 
and rich in isoflavones, which has a potential effect in reducing diabetes risk. The 
aim of this study is to determine the effect of soygurt consumption in blood glucose 
levels and body weight of albino wistar rats (Rattus norvegitus). Reseach using a 
completely randomized design for experimental study. Subjects of this research are 
30 male rats (R. norvegistus) aged 2-3 months with average body weight 150-200 gr. 
Diabetic rats were induced by using single intraperitoneal injection (175 mg/kg BW) 
alloxan monohydrate. Soygurt feeding given once daily using oral gavage feeding. 
The result showed that soygurt feeding in diabetic rats with three variations of 
treatment could significantly (p<0,05), lowering blood sugar level and improve body 
weight after 28 days of treatment. Treatment of 4ml/day soygurt has the highest 
effect in lowering blood sugar level and improving body weight, followed by treatment 
of 3ml/day and 2ml/day soygurt. 
Keyword: Soygurt, Type 2 Diabetes Mellitus, Blood Sugar Level, Body Weight, 
Rattus norvegitus 
 
INTRODUCTION  
Type 2 diabetes mellitus is a metabolic disorder characterized by 
hyperglycemia, which occurs due to abnormal insulin secretion, impaired insulin 
action, or both (Lathifah, 2013). Impaired action and resistance of insulin in type 2 
diabetes mellitus are associated with the incidence of intestinal microbial dysbiosis. 
Dysbiosis triggers chronic systemic low-grade inflammation, which causes 
decreased insulin sensitivity in the liver, muscles, and adipose tissue, which leads to 
insulin resistance (Allin et al., 2015). The regulation of intestinal microbial balances 
become urgent issues in type 2 diabetes mellitus patient, especially to maintain 
blood sugar balance and prevent complications (Astuti & Maulani, 2017).   
Gut microbiota plays a crucial role in control fermentation and absorption of 
dietary polysaccharides to produce short-chain fatty acids (SCFA), modulation host 
immune system, modulation of inflammatory processes, extraction of energy from 
the host diet and alterations of human gene expression (Blandino et al., 2016). The 
shift of gut microbiota from normobiosis to dysbiosis will effect the deficiency of 
microbiota compositional and functional diversity. Dysbiosis favors the overgrowth of 
Gram-negative bacteria and reducing Gram-positive bacteria (Ballak et al., 2014). 
The overgrowth of Gram-negative bacteria will affect in increasing production of 
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lipopolysaccharide (LPS) from bacteria cell walls. This condition may induce 
translocation of LPS and bacteria toxins across intestinal lumen into the blood 
circulation and triggers low-grade systemic inflammation, which plays a vital role in 
metabolic disorder and insulin resistance (Punder & Pruimboom, 2015). 
The abundance of gut microbial can be modulated directly through the 
consumption of probiotics and prebiotics (Azad et al., 2018). Probiotics are defined 
as living bacteria when administered in adequate amounts will confer a health benefit 
on the host. Probiotics products have used for centuries, especially in dairy foods 
such as yogurt and kefir (Ranadheera et al., 2017). Consumption of probiotics 
products based on cohort studies also known to be able to increase glutathione 
peroxidase activity and significantly reduce fasting blood sugar value, therefore 
suitable for people with glucose metabolic disorder (Lazar et al., 2019).   
Probiotics food that began to offer as a healthy diet for T2DM is probiotic 
yogurt (Barengolts et al., 2019). Yogurt is fermented milk with a low glycemic index 
(GI) and glycemic load (GL), which positively correlated in decreasing blood glucose 
(Wolever, 2017). Most commercial yogurt product is a dairy product based on cow's 
milk. As a cow's milk-based product, dairy yogurt may contain cholesterol based on 
the milk composition. Therefore the consistency of dairy yogurt in improving 
metabolism is still being debated (Madjd et al., 2016). Besides cow's milk, several 
studies state that yogurt also can be produced from vegetable milk, especially 
soymilk. Soymilk contains dietary fiber and relatively higher protein than cow's milk. 
Soymilk supplemented with lactose or glucose satisfies the requirement for lactic 
acid fermentation and is converted to edible yogurt-like dairy yogurt by lactic acid 
bacteria (Akusu & Wordu, 2017).  
Soymilk yogurt (soygurt) contains less or maybe not contain cholesterol 
depends on its composition. Its nutritional status can reduce the fears associated 
with high blood cholesterol and lactose of avid consumers of cow milk (Akusu & 
Wordu, 2017). Soymilk not only high in protein but also rich in isoflavones. 
Isoflavones are secondary metabolites producing by the Leguminosae plant, which is 
an excellent nutrient for regulating and stabilizing blood glucose. Isoflavone also has 
been shown to reduce the risk of diabetes in a laboratory study (Dan Ramdath et al., 
2017). Based on Konya et al. (2019) research, soy protein had intrinsic activity on 
glycemic control, and its isoflavones can improve insulin resistance and Low-Density 
Lipoprotein (LDL) in patients with T2DM. Nguyen et al. (2017) report that a higher 
intake of soymilk and major isoflavones (daidzein, genistein, and glycitein) was 
significantly associated with a lower risk of T2DM in Vietnamese adults. Uchitomi et 
al. (2019) state that genestein and daidzein in soy can positively increase beta-
oxidation and insulin sensitivity, which consequently decreasing fat concentration in 
blood and liver.   
 Fermented soymilk products may be beneficial from an economic than 
regular fermented milk products. From its nutritional point of view, soygurt contains 
dietary fiber and isoflavones, which can be a promising product for the T2DM diet. 
Some of the previous studies have reported that probiotics yogurt and soy milk 
consumption may reduce the risk of overweight and insulin resistance in T2DM. 
However, data directly relating dairy intake of soya yogurt (soygurt) to T2DM, and 
the effect of blood glucose and body weight remain sparse. Based on that, this study 
aimed to investigate the effect of daily soygurt consumption on blood glucose level 
and body weight in Wistar mice (Rattus norvegitus) with type 2 diabetes mellitus 
(T2DM). This present study also investigates the association between daily soygurt 
intake and lactic acid bacteria density in wistar mice with T2DM. 
Medical Laboratory Technology Journal   
 
Copyright © 2020, MLTJ, ISSN 2461-0879 
 
MATERIALS AND METHOD 
Soygurt production 
 Soymilk (85% v/v) and skim milk (15% v/v) pasteurized (± 600C ) and added 
1% sucrose, mixed well. After the pasteurization process, warmed milk until ± 400C 
and inoculated 10% starter (Streptococcus thermophilus and Lactobacillus 
bulgaricus; 1:1 in concentration) to fermented soygurt. Incubated in room 
temperature for 12 hours until soygurt thick and tangi and transport to the 
refrigerator.  Soygurt analyzed for fat, protein, and lactic acid content. Analysis 
conducted at the Faculty of Agricultural Technology Udayana University. 
Experimental animals 
 Ethical approval for this study provided by the Ethical Committee of Udayana 
University. Subjects of this research are 30 male Albino Wistar Rat Strain (Rattus 
norvegistus) aged 2-3 months with average body weight 150-200 gr. Animals were 
housed in clear sided cages (6/cage) at controlled temperature (22±20C) with an 
artificial 12-hr light-dark cycle and had free access to water and a standard pellet 
diet. Animals housed over one week acclimatization period before treatment.  
Diabetes induction 
 Twenty four rats had fasted for 12-hours before diabetes-induced using 
alloxan monohydrate (Sigma Aldrich™) using single intraperitoneal injection (175 
mg/kg BW). Meanwhile, six rats injected with saline solution and served as a 
negative control group (G1). After 72 hours and 96 hours of diabetes-induced groups 
and negative control, groups tested for fasting blood glucose levels using Glucose 
meter KIT (Easy Touch GCU). Blood is collected using a syringe needle from the 
lateral tail vein. Diabetes type 2 induced rats have fasting blood sugar > 200 mg/dl; 
meanwhile, normal rats have fasting blood sugar levels <100-120 mg/dl.  
Study design 
Reseach using Completely Randomized Design for experimental study. 
Experimental design using five groups, each group consists of 6 subjects. The 
treatment period for this study was 28 days. Diabetic rats randomly divided into four 
groups. Soygurt feeding given once daily at 08.00 a.m using an oral gavage needle. 
Each group in this study had different treatment for soygurt diet that is : 
 
No. Group Treatment 
1. First Group (G1) Non-diabetic/ negative control group without soygurt diet 
treatment 
2. Second Group (G2) Diabetic/ positive control group without soygurt diet 
treatment 
3. Third Group (G3) The diabetic group with 2 ml soygurt diet treatment 
every day for 28 days 
4. Fourth Group (G4) The diabetic group with 3 ml soygurt diet treatment 
every day for 28 days 
5. Fifth Group (G5) The diabetic group with 4 ml soygurt diet treatment 
every day for 28 days 
 
Parameter analysis 
Every week (7th, 14th, 21st and 28th days), animals were tested for blood sugar 
level using Glucose Meter Kit (Easy Touch GCU), body weight, and lactic acid 
bacteria count in feces. Lactic acid bacteria counted using Standard Plate Count 
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(SPC) and inoculated in MRS Agar (de Man, Rogosa, and Sharpe Agar Merck™) 
with 1% CaCO3.  
Statistical Analyses 
 Statistical analyses carried out using Mini Tab (Minitab Pty Ltd) Program 
version 19 for Windows. All data were expressed as mean ± standard deviation, 
General Linear Model (GLM) ANOVA and Duncan Multiple Range Test (DMRT) to 
differentiate the significance of treatment of each group. P value <0,05 were 
considered to be significant.  
 
RESULTS AND DISCUSSION 
Type 2 Diabetes Mellitus (T2DM) Induction in Rats 
 Healthy rats in acclimatization stage have normal blood sugar values in the 
range of 105-111 mg/dL and average body weight 167-191 gram. After induction of a 
single intraperitoneal dose of 175 mg/kg BW alloxan monohydrate, blood sugar in 
rats increases significantly than negative control treatment (G1) (p<0,05) (Table 1). 
Alloxan induction positively causes a metabolic syndrome of T2DM in rats by 
increasing fasting blood glucose value in range 465-520 mg/dL. Alloxan induction 
also affecting body weight in diabetic rats significantly (p<0,05). Based on the 
calculation of fecal microbes, it can conclude that T2DM induction on rats did not 
affect lactic acid bacteria density. This happening evidenced by the lactic acid 
bacteria density (log10 CFU/gr) was not significantly different (p<0,05) than the 
negative control group (G1). Lactic acid bacteria density before alloxan induction 
was 8,32-8,42 log10 CFU/ gr in range and after treatment 8,15-8,40 log10 CFU/ gr in 
range and were not significantly different based on the DMRT test. 
 
Table 1. Result of Type 2 Diabetes Mellitus Induction in Rats 
 
No. Group 
Acclimatization 
After Diabetic Type 2 
Treatment 
Blood 
sugar 
(mg/dl) 
Body 
Weight 
(gram) 
Lactid 
Acid 
Bacteria 
(log10 
cfu/g) 
Blood 
sugar 
(mg/dl) 
Body 
Weight 
(gram) 
Lactid 
Acid 
Bacteria 
(log10 
cfu/g) 
1. G1  111 ± 
10,49a 
191,667 
± 13,43a 
8.34 ± 
0.24a 
103 ± 
11,85b 
190,000 ± 
12,90a 
8.39 ± 
0.29a 
2. G2  109 ± 
7,66a 
172,500 
± 17,26a 
8.42 ± 
0.35a 
520 ± 
35,36a 
161,667 ± 
26,87ab 
8.32 ± 
0.32a 
3. G3 106 ± 
13,65a 
169,167 
± 18,808a 
8.32 ± 
0.29a 
497 ± 
52,58a 
146,667 ± 
24,94b 
8.24 ± 
0.22a 
4. G4 105 ± 
10,48a 
168,333 
± 13,43a 
8.35 ± 
0.20a 
470 ± 
74,51a 
146,667 ± 
21,14b 
8.15 ± 
0.22a 
5. G5 105 ± 
7,67a 
167,500 
± 20,36a 
8.33 ± 
0.26a 
465 ±  
52,20a 
136,667 ± 
18,63b 
8.40 ± 
0.32a 
Notes : Means that do not share a letter (a, b, c) are significantly different (p<0,05). 
G1: Negative control group (non-diabetic type 2 inducing rats). Data are mean 
values from six repetitions 
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Effect of soygurt on blood glucose level  
 The blood glucose level of diabetic rats after soygurt feeding treatment with a 
various volume of 2 ml, 3ml, and 4ml is consistently decreased every week. Soygurt 
feeding on rats for four weeks significantly reduced blood glucose levels compared 
to a positive control (without soygurt feeding treatment). In the first week, G4 (3ml 
soygurt/ day) and G5 (4ml soygurt/day) treatment have been able to reduce blood 
sugar as indicated by significantly blood sugar value compared to the positive 
control. Meanwhile, G3 (2ml soygurt/day) treatment showed significantly different 
blood sugar levels in third weeks feeding compared to the positive control. After four 
weeks of soygurt feeding, it was known that G3 group blood sugar decrease by 
40,84%, G4 by 42,34%, and G5 by 51,39% from 0 weeks before treatment. G5 (4ml 
soygurt/day) is known as the best treatment to reduce blood sugar levels in rats. In 
the fourth week of treatment, the blood sugar level in G5 was 226±66,94 mg/dl on 
average, which is almost equal compared to the healthy group (G1) group (Table 2).  
 
Table 2. Effect of soygurt on rat’s glucose level 
 
No. Group 
Blood Glucose (mg/dl) 
1st week 2nd week 3rd week 4th week 
1. G1 (negative 
control/ healthy 
rats)  
115±14,20c 95±13,55c 103±6,52c 93±5,69c 
2. G2 (T2DM rats/ 
positive control) 
542±53,75a 498±56,18a 534±39,60a 528±59,64a 
3. G3 (T2DM rats with 
2 ml soygurt diet) 
407±99,99ab 362±86,72ab 350±119,40b 294±103,38b 
4. G4 (T2DM rats with 
3 ml soygurt diet) 
361±67,08b 302±76,48b 303±65,77b 271±97,13b 
5. G5 (T2DM rats with 
4 ml soygurt diet) 
333±83,62b 285±104,94b 290±109,33b 226±66,94bc 
Notes: Data are mean values from six repetitions. Means that do not share a letter 
(a, b, c) are significantly different (p<0,05).  
 
Effect of soygurt on body weight  
Healthy rats (G1) had normal body weight fluctuation every week. Meanwhile, 
rats with T2DM had drastic bodyweight loss in the first week. Rats with T2DM 
without soygurt supplementation (G2) in the fourth week had an average body 
weight of 107,500±5,59 or decreased by 33,50% from 0 weeks after alloxan 
induction. Soygurt diet based on statistical analysis had a positive effect on weight 
improvement in rats with T2DM. After four weeks of soygurt feeding in G3, G4, and 
G5, the bodyweight average was significantly different from T2DM rats with a non-
soygurt diet (G2) (Table 3). Soygurt with 4ml/ day dose known to have the best effect 
on increasing body weight in T2DM rats.   
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Table 3. Effect of soygurt on rat’s body weight 
 
No. Group 
Body Weight (gram) 
1st week 2nd week 3rd week 4th 
week 
1. G1 (negative control/ healthy 
rats)  
186,667 
± 13,74a 
186,667 
± 11,05a 
209,167 
± 7,31a 
218,333 
± 12,13a 
2. G2 (T2DM rats/ positive 
control) 
133,333 
± 14,62b 
123,333 
± 6,87b 
115,833 
± 4,48c 
107,500 
± 5,59c 
3. G3 (T2DM rats with 2 ml 
soygurt diet) 
140,833 
± 20,89b 
130,000 
± 20,81b 
134,167 
± 
21,291bc 
145,000 
± 34,03b 
4. G4 (T2DM rats with 3 ml 
soygurt diet) 
140,833 
± 14,33b 
131,667 
± 15,72b 
138,333 
± 21,14bc 
149,167 
± 19,23b 
5. G5 (T2DM rats with 4 ml 
soygurt diet) 
137,500 
± 15,20b 
186,667 
± 17,26b 
156,667 
± 21,34b 
156,167 
± 9,42b 
Notes: Data are mean values from six repetitions. Means that do not share a letter 
(a, b, c) are significantly different (p<0,05).  
 
Effect of soygurt on lactic acid bacteria density  
In the first week after T2DM induction, there was no significant difference 
between lactic acid bacteria density in healthy and T2DM rats' feces. The effect of 
T2DM syndrome on lactic acid bacteria density appeared in the second week with a 
significant difference between G2 and G1 group. This result shows that the induction 
of T2DM has an effect on reducing lactic acid bacteria in faeses. Daily feeding of 
soygurt in T2DM rats based on statistical analysis is known to be able to increase 
lactic acid bacteria density in feces. In the second week of treatment, daily feeding of 
2ml of soygurt (G2) was able to balance lactic acid bacteria density and was not 
significantly different from healthy rats (G1). Meanwhile, daily feeding of 3 ml and 4 
ml soygurt significantly increase lactic acid bacteria compared to G1 and G2. In the 
last week of treatment, daily soygurt feeding in G3, G4, and G5 were significantly 
increasing lactic acid bacteria density in feces of T2DM rats.  
 
Table 4. Effect of soygurt on lactic acid bacteria density  
 
No. Group 
Lactic Acid Bacteria density (log10 CFU/gram)  
1st week 2nd week 3rd week 4th week 
1. G1 (negative control/ 
healthy rats)  
8.28 ± 
0.38a 
8.57 ± 
0.75b 
8.54 ± 
0.04b 
8.51 ± 
0.24b 
2. G2 (T2DM rats/ positive 
control) 
8.18 ± 
0.30a 
8.04 ± 
0.23a 
7.99 ± 
0.20a 
8.00 ± 
0.16a 
3. G3 (T2DM rats with 2 ml 
soygurt diet) 
8.16 ± 
0.32a 
8.65 ± 
0.83b 
8.65 ± 
0.64b 
9.36 ± 
0.23c 
4. G4 (T2DM rats with 3 ml 
soygurt diet) 
8.15 ± 
0.41a 
9.28 ± 
0.44c 
9.69 ± 
0.48c 
9.80 ± 
0.69c 
5. G5 (T2DM rats with 4 ml 
soygurt diet) 
8.40 ± 
0.32b 
9.46 ± 
0.31c 
9.71 ± 
0.15c 
9.70 ± 
0.15c 
Notes: Data are mean values from six repetitions. Means that do not share a letter 
(a, b, c) are significantly different (p<0,05).  
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Gross composition of soygurt  
 The result of the gross composition of soygurt presented in Table 5. Based on 
data analysis, soygurt product has balance composition for protein, fat, and lactic 
acid.  
Table 5. Composition of soygurt 
 
No. Product Protein (%FW) Fat (%FW) Lactic Acid 
(%FW) 
1 Soygurt 4,1972 4,6636 4,0826 
 
 Yogurt products are generally produced from cow's milk as raw material and 
well known as milk-based yogurt. In soygurt, cow milk is replaced by soy milk, which 
has a similar nutritional value and a good source of protein (Messina, 2016). 
Serlahwaty et al. (2015) state that end product of soygurt is usually thinner than milk-
based yogurt. To make it thicker skim milk usually adds as a thickener addictive. 
Skim milk in soygurt fermentation can increase the total of non-fat solids, improving 
consistency and viscosity and coagulant formation. The result of gross composition 
analysis showed that soygurt contains protein 4,1972% and fat 4,6636% (Table 5) 
and accordance with quality requirements based on SNI 2981:2009. However, lactic 
acid composition in the product was not following SNI 2981:2009 and needed to 
evaluate. According to Mulyani et al. (2016), it can be evaluated by giving different 
variations of temperature and fermentation time in soygurt preparation. 
 Soygurt products in the present study tested to determine its benefits in blood 
sugar level, body weight, and lactic acid bacteria density in rat feces. The test was 
performed on male albino Wistar rats with T2DM positive (blood sugar > 200 mg/dl). 
Induction of T2DM was carried out by inducing rats with a single intraperitoneal dose 
of 175mg/kg alloxan monohydrate. Results showed that alloxan could positively 
cause hyperglycemia in rats with fasting blood sugar value 465-529 mg/dl and 
significantly different (p<0,05) with negative control (G1) (Table 1). Rats after T2DM 
induction also experienced significant weight loss and different (p<0,05) from 
negative control after four days of conditioning (Table 1). Based on significant fasting 
blood sugar values (>400 mg/dl) and significant weight loss, it can be concluded that 
T2DM conditioning in experimental rats has been achieved. 
 This present study was similar to previous findings by Utami et al. (2015) that 
have reported that alloxan monohydrate had a positive effect as diabetogenic in rats 
to perform T2DM syndrome. Research by (Husni et al., 2016) showed that the 
administration of alloxan in rats led to a significant increase in blood glucose levels 
after three days. Alloxan induced diabetic rats did not show a significant decrease in 
body weight after the induction. However, body weight had decreased in 15 days of 
treatment and significantly different from the healthy rat group. Alloxan is 
diabetogenic that can induce T2DM conditions in animals in a relatively short period. 
As a strong oxidant, alloxan can increase the generation of reactive oxygen species 
from metabolic reactions in the body. Together with the massive increase of cytosolic 
calcium concentration, it can rapidly cause the destruction  of pancreatic β-cells 
(Susilawati et al., 2014; Ighodaro et al., 2018). Alloxan-induced diabetes in rats also 
can trigger liver morphological and ultrastructural changes that closely resembled 
human disease (Lucchesi et al., 2015). 
 This present study showed that soygurt feeding in diabetic rats with three 
variations of treatment could significantly (p<0,05), lowering the blood sugar level in 
the third week of treatment. The best dose for lowering blood glucose levels quickly 
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was 4ml/ day (G5). Treatment of 4ml/day soygurt in the first week was able to lower 
blood glucose levels significantly compared to the diabetic control group. In 0 weeks 
before soygurt feeding treatment, the average blood sugar level in G5 diabetic rats 
was 465±52,2 mg/dl, after four weeks of 4ml soygurt feeding blood sugar levels was 
226±66,94 mg/dl (Table 2) or decreased by 51,39%. Treatment of 2ml and 3ml 
soygurt also had a positive effect on lowering the blood sugar level in diabetic rats 
because it was significantly different (p<0,05) from control (G2) (Table 2). This result 
also supports the previous study by Sartang et al. (2015) that reported the effect of 
probiotic soymilk fortified with Omega-3 in rats induced with Streptozotocin 
Nicotinamide, which significantly reduced blood sugar levels. Riyanto & Muwarni 
(2015) also report that soy fermentation products can lower blood sugar and low-
density lipoprotein (LDL) in hypercholesterolemia rats. Choi et al. (2016) also 
reported that soy fermentation with probiotic Licheniformis-67, significantly lowering 
blood sugar, insulin levels, serum, and hepatic lipid profiles. 
In this study, there was a significant reduction in body weight in diabetic rats 
after alloxan induction. Healthy rats in the G1 group were in generally good condition 
and had progressive weight gain every week. In the fourth week of treatment, 
average body weight in G1 was 218,333±12,13 gram, and significantly different from 
diabetics rats (G2) with average bodyweight 107,500±5,59 gram (Table 3). The 
weight loss may be due to the catabolic processes involved in diabetes mellitus. 
From the first week of soygurt feeding in 2ml (G3), 3ml (G4), and 4ml (G5) volume, 
body weight in diabetic rats were significantly increased compared to non-yogurt 
treatment diabetic rats (G2). The result in this present study showed that daily 
soygurt feeding in diabetic rats could improve body weight in diabetic rats; this may 
be attributed to the mitigation of catabolic processes by soygurt. This present study 
support previous research by Veerichetty (2018), who also stated that a combination 
of soymilk and flaxseed milk fermentation could significantly increase body weight in 
diabetic rats in the first week of treatment.   
In general, the result of this study support another research related to 
potential probiotics products, especially soygurt, as a healthy diet on T2DM. 
Jayaswal & Prabhakar (2017) stated that probiotics bacteria such as Lactobacillus 
acidophilus and Bifidobacterium bifidum have a vital role in helping stabilize blood 
sugar levels. Kasińska & Drzewoski (2015) revealed that probiotic bacteria in yogurt 
could help maintain intestinal microbiota. These effects inhibit the transfer of 
bacterial endotoxins into the bloodstream and reduce the production of a pro-
inflammatory cytokine to reduce inflammatory response through neutralizing 
circulating lipopolysaccharides (LPS). Decreased inflammation will correlate in 
lowering insulin resistance, and blood glucose levels can be controlled. Based on the 
result in the present study (Table 4), daily soygurt feeding in diabetic rats 
significantly increased lactic acid bacteria density in feces compared to healthy rats 
(control group G2). Statistical analysis showed that an increase of lactic acid bacteria 
in feces was positively correlated with blood sugar decrease in diabetic rate, so it 
can be concluded that soygurt feeding was able to improve gut microbial dysbiosis 
due to T2DM syndrome.  
Soygurt effectiveness in lowering the T2DM effect can be influenced by the 
high content of soy milk in the product. Soymilk, according to Bintari et al. (2015), is 
rich in isoflavones, which are commonly known as antihyperglycemic agents. Soy 
isoflavones are active biological substances with estrogen-like chemical structures. 
Several epidemiological types of research have associated isoflavone consumption 
by reducing the risk of diabetes and diabetes-related complications. Soybeans 
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naturally contain isoflavones, including genistein (El-kordy & Alshahrani, 2015), 
daidzein, and glycitein (Sahin et al., 2019). Genistein, as predominant natural soy 
isoflavone, has a protective effect on pancreatic β-cells damage, possesses the 
ability to regenerate β-cells, and improves serum levels of insulin and glucose in 
STZ-induced diabetic rats. It can be concluded that genistein in soy is an anti 
diabetogenic potential agent for T2DM. High dosage of genistein possesses the 
ability to regenerate β-cells that results in increasing the lowered serum insulin and 
consequently decreasing high serum glucose in diabetic rats (El-kordy & Alshahrani, 
2015).   
The result of this study showed that soygurt product was effective in 
improving metabolism in T2DM rats in terms of their ability to lowering blood sugar 
levels, improving body weight, and lactic acid bacteria. The fermentation process in 
soygurt is an efficient way to produce bioactive peptides; it also promotes protein 
digestion and solubilization of calcium and improves the health and immune system 
(Veerichetty, 2018). Probiotic supplementation is positively correlated with gut 
microbiota modification, and it may be a method for preventing and control 
hyperglycemia in clinical practice (Wu et al., 2015).  
The limitation of this study has not yet analyzed the correlation of soygurt 
consumption on improving gut microbiota and its effect on blood sugar levels. 
Further studies with similar objectives are recommended to evaluate soygurt 
adjunctive therapy for T2DM and its correlation in gut microbiota modification. We 
recognize our results in this animal model study may not powerful enough to predict 
the effects of soygurt in blood sugar and body weight balancing in humans with 
T2DM. Lastly, we recommend using a large number of animal studies and an equal 
number of controls to provide more statistical robustness of the effect of soygurt 
consumption in blood sugar and body weight balancing in T2DM syndrome.  
 
CONCLUSION 
Soygurt consumption have a positive effect on lowering blood glucose levels 
in rats with Type 2 Diabetes Mellitus. Daily soygurt consumption was also effective in 
improving the rat's body weight after 28 days of treatment. 
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